ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.54
0.00%
US Tech 100
19,123.20
-0.44%
S&P 500
5,462.87
-0.03%
US Dollar vs CAD
1.36797
-0.16%
Bitcoin
61,343.83
-2.87%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aziyo Biologics Inc (AZYO)

  7. Aziyo Biologics Inc (AZYO) News

AZYO

Aziyo Biologics (AZYO)

Aziyo Biologics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AZYO
DateTimeSourceHeadlineSymbolCompany
04/22/20243:33PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AZYOAziyo Biologics Inc
04/22/20243:30PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AZYOAziyo Biologics Inc
04/01/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
09/08/20237:30AMGlobeNewswire Inc.Elutia to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AZYOAziyo Biologics Inc
09/07/20237:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
09/06/20233:05PMGlobeNewswire Inc.Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting BiomatricesNASDAQ:AZYOAziyo Biologics Inc
08/30/20237:30AMGlobeNewswire Inc.Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative ProceduresNASDAQ:AZYOAziyo Biologics Inc
08/14/20234:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AZYOAziyo Biologics Inc
08/14/20233:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
08/14/20233:05PMGlobeNewswire Inc.Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix CompanyNASDAQ:AZYOAziyo Biologics Inc
07/31/20233:05PMGlobeNewswire Inc.Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023NASDAQ:AZYOAziyo Biologics Inc
07/17/20233:05PMPR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:AZYOAziyo Biologics Inc
07/13/20234:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
07/13/20233:30PMGlobeNewswire Inc.Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix ProductsNASDAQ:AZYOAziyo Biologics Inc
06/23/202310:31AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZYOAziyo Biologics Inc
06/12/202310:32AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZYOAziyo Biologics Inc
06/09/20233:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZYOAziyo Biologics Inc
05/19/20237:15AMGlobeNewswire Inc.Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic EnvelopeNASDAQ:AZYOAziyo Biologics Inc
05/12/20234:16PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AZYOAziyo Biologics Inc
05/10/20233:05PMGlobeNewswire Inc.Aziyo Biologics Reports Highest Sales and Gross Profit in Company HistoryNASDAQ:AZYOAziyo Biologics Inc
05/03/20233:05PMGlobeNewswire Inc.Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023NASDAQ:AZYOAziyo Biologics Inc
04/20/20233:30PMGlobeNewswire Inc.Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo’s Cardiovascular PortfolioNASDAQ:AZYOAziyo Biologics Inc
04/07/20235:01AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AZYOAziyo Biologics Inc
03/23/20234:10PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:AZYOAziyo Biologics Inc
03/22/20233:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZYOAziyo Biologics Inc
03/22/20233:01PMGlobeNewswire Inc.Aziyo Biologics Reports Record Full Year 2022 RevenuesNASDAQ:AZYOAziyo Biologics Inc
03/22/20237:30AMGlobeNewswire Inc.Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue ReconstructionNASDAQ:AZYOAziyo Biologics Inc
03/20/20234:27PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZYOAziyo Biologics Inc
03/20/20237:00AMGlobeNewswire Inc.Aziyo Biologics Provides Update on FDA Submission for CanGaroo® RM Antibacterial EnvelopeNASDAQ:AZYOAziyo Biologics Inc
03/15/20233:05PMGlobeNewswire Inc.Aziyo Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 22, 2023NASDAQ:AZYOAziyo Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:AZYO

Your Recent History

BOV
TASA4R
FORJA TAURUS PN
BIT
F37052
Vontobel Financial Produ...
TSX
GMNG
Gamelancer Media
BIT
P20HZ3
NLBNPIT20HZ3 20991231 25...
NASDAQ
OCS
Oculis
NASDAQ
SHRY
First Trust ETF VI First...
USOTC
KNCRY
Konecranes (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved